Lab News
Big data can improve familial hypercholesterolemia screening
October 23, 2019 -- A machine-learning algorithm may be useful for scanning electronic health records to spot people with undiagnosed familial hypercholesterolemia based on a mix of lab reports and other data, according to a study supported by big pharma and published in Lancet Digital Health on October 21.
Discuss
October 23, 2019 -- A machine-learning algorithm may be useful for scanning electronic health records to spot people with undiagnosed familial hypercholesterolemia based on a mix of lab reports and other data, according to a study supported by big pharma and published in Lancet Digital Health on October 21.
Discuss Veracyte nasal swab test holds its own in lung cancer detection
October 22, 2019 -- Veracyte said the accuracy of its investigational nasal swab genomic classifying test rivals the clinical standard for lung nodule assessment and has potential to spare unnecessary follow-up in suspected cancer cases, based on preliminary data presented on October 22 at the Chest annual meeting of the American College of Chest Physicians in New Orleans.
Discuss
October 22, 2019 -- Veracyte said the accuracy of its investigational nasal swab genomic classifying test rivals the clinical standard for lung nodule assessment and has potential to spare unnecessary follow-up in suspected cancer cases, based on preliminary data presented on October 22 at the Chest annual meeting of the American College of Chest Physicians in New Orleans.
Discuss Cheap vaginal-fluid testing signals risk for premature birth
October 22, 2019 -- Low-cost testing of vaginal fluid could flag risk factors for preterm birth and could be useful at the point of care in resource-poor settings to reduce life-threatening complications, according to a study of pregnant women in Brazil published on October 22 in mBio, the journal of the American Society for Microbiology.
Discuss
October 22, 2019 -- Low-cost testing of vaginal fluid could flag risk factors for preterm birth and could be useful at the point of care in resource-poor settings to reduce life-threatening complications, according to a study of pregnant women in Brazil published on October 22 in mBio, the journal of the American Society for Microbiology.
Discuss Technique overcomes barriers of next-generation sequencing in cancer
October 21, 2019 -- A low-cost investigational technique for assessing copy number alterations helps identify cancers that are aggressive, enabling clinicians to guide treatment accordingly, researchers at the Karolinska Institutet in Sweden reported in Nature Communications online October 18.
Discuss
October 21, 2019 -- A low-cost investigational technique for assessing copy number alterations helps identify cancers that are aggressive, enabling clinicians to guide treatment accordingly, researchers at the Karolinska Institutet in Sweden reported in Nature Communications online October 18.
Discuss NIH-funded Lyme test promises better results, at the point of care
October 17, 2019 -- A rapid microfluidics assay for Lyme disease performed better than a standard lab workup and shows promise for use as a single diagnostic test at the point of care, according to a new study funded by the U.S. National Institutes of Health (NIH).
Discuss
October 17, 2019 -- A rapid microfluidics assay for Lyme disease performed better than a standard lab workup and shows promise for use as a single diagnostic test at the point of care, according to a new study funded by the U.S. National Institutes of Health (NIH).
Discuss Amino acid blood test illuminates abdominal aneurysms
October 16, 2019 -- The level of the amino acid desmosine in the blood is a good biomarker for potentially deadly abdominal aortic aneurysms and complements measurements of aneurysm size from imaging studies, U.K. researchers reported online October 9 in the Journal of the American Heart Association.
Discuss
October 16, 2019 -- The level of the amino acid desmosine in the blood is a good biomarker for potentially deadly abdominal aortic aneurysms and complements measurements of aneurysm size from imaging studies, U.K. researchers reported online October 9 in the Journal of the American Heart Association.
Discuss Pathology study challenges conventional wisdom on brain injury
October 15, 2019 -- During a large study of traumatic brain injury, a middle-aged man died and his family donated his brain for research: It was an unusual opportunity to determine the true pathology underlying his condition. Results were reported on October 14 in the journal Brain.
Discuss
October 15, 2019 -- During a large study of traumatic brain injury, a middle-aged man died and his family donated his brain for research: It was an unusual opportunity to determine the true pathology underlying his condition. Results were reported on October 14 in the journal Brain.
Discuss Growing AI healthcare market boasts variety of deployments
October 14, 2019 -- Bruce Carlson, publisher of Kalorama Information, charts the growth of artificial intelligence (AI) applications in healthcare. The global market is set to reach $11.4 billion by 2024, according to a new report.
Discuss
October 14, 2019 -- Bruce Carlson, publisher of Kalorama Information, charts the growth of artificial intelligence (AI) applications in healthcare. The global market is set to reach $11.4 billion by 2024, according to a new report.
Discuss FDA airs 'to do' list for devices in 2020
October 14, 2019 -- The U.S. Food and Drug Administration's (FDA) priorities for new guidance documents on medical devices in fiscal 2020 include updated recommendations for CLIA waiver applications for IVD device manufacturers, as well as updates for managing cybersecurity.
Discuss
October 14, 2019 -- The U.S. Food and Drug Administration's (FDA) priorities for new guidance documents on medical devices in fiscal 2020 include updated recommendations for CLIA waiver applications for IVD device manufacturers, as well as updates for managing cybersecurity.
Discuss In a first for U.S., FDA clears OraQuick rapid Ebola test
October 10, 2019 -- OraSure Technologies' OraQuick has become the first rapid diagnostic for detecting Ebola virus antigens to win marketing clearance from the U.S. Food and Drug Administration (FDA). The FDA's move should pave the way for similar diagnostic products to gain standard market entry.
Discuss
October 10, 2019 -- OraSure Technologies' OraQuick has become the first rapid diagnostic for detecting Ebola virus antigens to win marketing clearance from the U.S. Food and Drug Administration (FDA). The FDA's move should pave the way for similar diagnostic products to gain standard market entry.
Discuss
News in Brief
Conferences
American Society for Clinical Pathology (ASCP) Workshops for Laboratory Professionals
October 23-25
Anaheim, California United States
October 23-25
Anaheim, California United States
Interactive Microscopy
October 23-26
Palm Springs, California United States
October 23-26
Palm Springs, California United States
American Association for Clinical Chemistry (AACC) Middle East
November 1-2
Dubai, Dubai United Arab Emirates
November 1-2
Dubai, Dubai United Arab Emirates
Pathology Update
November 1-2
Toronto, Ontario Canada
November 1-2
Toronto, Ontario Canada
Contemporary Issues in Urologic Pathology
November 4-7
San Francisco, California United States
November 4-7
San Francisco, California United States
Connect
Latest Tweets